Glycosyl compounds
Medchemexpress LLC X-gluc (cyclohexanamine) | 114162-64-0 | MFCD00058543 | 99.8% | 521.79 g·mol⁻1 | C20H26BrClN2O7 | 10 MG
X-gluc (cyclohexanamine) is a chromogenic substrate for β-glucuronidase (GUS). When enzymatically cleaved it produces an insoluble blue precipitate, enabling visual detection of GUS activity in microbiological and molecular biology assays.
- Chromogenic substrate that yields a blue precipitate upon GUS cleavage.
- High purity (≈99.8%), suitable for research applications.
- Solid, white to off-white appearance for easy handling.
- Soluble in DMSO up to 100 mg/mL; ultrasonic assistance may be required.
- Recommended storage: 4°C, protected from light; in solution store at -80°C for long term.
- Supplied in small pack sizes for assay-scale experiments.
- Intended for research use only.
Apexbio Technology LLC Anti-Amyloid-Beta-Ab-Donanemab
Anti-Amyloid Beta Antibody (Donanemab) (CAS No 1931944-80-7) is a monoclonal antibody under investigation in the field of neurodegenerative research specifically for Alzheimer s disease Originating from biotechnology developments its primary mechanism involves targeting amyloid beta plaques which are believed to contribute to Alzheimer s pathology It binds to a specific epitope on deposited amyloid plaques promoting clearance and reducing their accumulation Common in vitro activity has been observed in the nanomolar to low micromolar range Typical applications include use in cell models animal studies and drug screening assays to assess efficacy and mechanistic pathways Experimental concentrations typically depend on the specific research design
Apexbio Technology LLC Anti-Amyloid Beta Solanezumab
Anti-Amyloid Beta Antibody (Solanezumab) (CAS No 955085-14-0) is a monoclonal antibody used in Alzheimer s research originating from Eli Lilly and Company It specifically targets amyloid beta plaques implicated in Alzheimer s pathogenesis by binding to soluble monomers thereby reducing plaque formation Solanezumab s action is primarily observed in the modulation of amyloid beta clearance mechanisms within the central nervous system In vitro activity typically occurs in the nanomolar range reflecting its high affinity and specificity for amyloid beta peptides It s commonly applied in cell models and animal studies to evaluate therapeutic potential particularly in transgenic mice expressing human amyloid precursor protein Additionally Solanezumab is prominent in drug screening processes for Alzheimer s therapeutics Experimental concentrations typically depend on the specific research design ensuring flexibility in dose-response assessments across different methodologies
Sigma Aldrich Fine Chemicals Biosciences Thiocolchicoside >=98% (HPLC) | 602-41-5 | MFCD07995056 | 25MG
Thiocolchicoside >=98% (HPLC) | Purity: >=98% (HPLC) | Mol Wt: 563.62 | 602-41-5 | MFCD07995056 | 25MG
Medchemexpress LLC Lauryl glucoside | 110615-47-9 | MFCD19980983 | 50.0% | 348.5 g/mol | C18H36O6 | 500 MG
Lauryl glucoside (50% in water) is a non-ionic surfactant supplied as a 50% w/w aqueous solution. It delivers effective cleansing and high foaming performance while maintaining mild skin compatibility, making it suitable for research and formulation applications requiring a gentle, water-based surfactant.
- Non-ionic surfactant with high cleansing ability
- High foaming capacity for effective formulation performance
- Mild and biodegradable, suitable for gentle applications
- Supplied as a 50% aqueous solution for easier handling and dosing
- Useful for cleansing, emulsifying, and foaming formulations
eMolecules 6734-33-4 | 4-Methylumbelliferyl-b-D-xylopyranoside | Chem-Impex308.286 | C15H16O7 | 98.000 | Cc1cc(=O)oc2cc(OC3OCC(O)C(O)C3O)ccc12 | 1g | 112755844
4-Methylumbelliferyl-b-D-xylopyranoside | Chem-Impex | 6734-33-4308.286 | C15H16O7 | 98.000 | Cc1cc(=O)oc2cc(OC3OCC(O)C(O)C3O)ccc12 | 1g | 112755844